| 05/03/2024 | AMGN | Buy Now | Amgen | $319.04 | -5.97% | $230 → $300 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $142.00 | 19.01% | $150 → $169 | Maintains | Overweight | Get Alert |
| 04/29/2024 | GILD | Buy Now | Gilead Sciences | $67.12 | 13.23% | $80 → $76 | Maintains | Equal-Weight | Get Alert |
|
| 04/29/2024 | ABBV | Buy Now | AbbVie | $163.89 | 14.1% | $195 → $187 | Maintains | Overweight | Get Alert |
| 04/26/2024 | BMY | Buy Now | Bristol-Myers Squibb | $44.55 | -3.48% | $51 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | BIIB | Buy Now | Biogen | $235.32 | -15.01% | $215 → $200 | Maintains | Equal-Weight | Get Alert |
| 04/16/2024 | SKIL | Buy Now | Skillsoft | $8.29 | 141.25% | $25 → $20 | Maintains | Overweight | Get Alert |
| 04/04/2024 | BIIB | Buy Now | Biogen | $235.32 | -8.64% | $230 → $215 | Maintains | Equal-Weight | Get Alert |
| 03/27/2024 | ABBV | Buy Now | AbbVie | $163.89 | 18.98% | $185 → $195 | Maintains | Overweight | Get Alert |
| 02/29/2024 | ACLX | Buy Now | Arcellx | $51.72 | 41.14% | $62 → $73 | Maintains | Overweight | Get Alert |
| 02/12/2024 | GILD | Buy Now | Gilead Sciences | $67.12 | 19.19% | $85 → $80 | Maintains | Equal-Weight | Get Alert |
| 02/05/2024 | ABBV | Buy Now | AbbVie | $163.89 | 12.88% | $175 → $185 | Maintains | Overweight | Get Alert |
| 02/02/2024 | MRK | Buy Now | Merck & Co | $132.00 | 9.85% | $135 → $145 | Maintains | Overweight | Get Alert |
| 01/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $980.20 | 4.06% | $935 → $1020 | Maintains | Overweight | Get Alert |
| 01/23/2024 | NBIX | Buy Now | Neurocrine Biosciences | $142.00 | 5.63% | $145 → $150 | Maintains | Overweight | Get Alert |
| 01/23/2024 | MRK | Buy Now | Merck & Co | $132.00 | 2.27% | $130 → $135 | Maintains | Overweight | Get Alert |
| 01/23/2024 | GILD | Buy Now | Gilead Sciences | $67.12 | 26.64% | $82 → $85 | Maintains | Equal-Weight | Get Alert |
| 01/23/2024 | LLY | Buy Now | Eli Lilly | $788.00 | -13.71% | $630 → $680 | Maintains | Overweight | Get Alert |
| 01/23/2024 | ABBV | Buy Now | AbbVie | $163.89 | 6.78% | $170 → $175 | Maintains | Overweight | Get Alert |
| 01/17/2024 | ALLK | Buy Now | Allakos | $1.18 | -15.25% | $1.5 → $1 | Maintains | Underweight | Get Alert |
| 12/14/2023 | PFE | Buy Now | Pfizer | $28.80 | -2.78% | $34 → $28 | Maintains | Equal-Weight | Get Alert |
| 12/06/2023 | SKIL | Buy Now | Skillsoft | $8.29 | 261.88% | $37 → $30 | Maintains | Overweight | Get Alert |
| 11/16/2023 | ACLX | Buy Now | Arcellx | $51.72 | 19.88% | $49 → $62 | Maintains | Overweight | Get Alert |
| 11/14/2023 | ALLK | Buy Now | Allakos | $1.18 | 27.12% | $2.5 → $1.5 | Maintains | Underweight | Get Alert |
| 11/01/2023 | PFE | Buy Now | Pfizer | $28.80 | 18.06% | $35 → $34 | Maintains | Equal-Weight | Get Alert |
| 10/30/2023 | ABBV | Buy Now | AbbVie | $163.89 | 3.73% | $160 → $170 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $44.55 | 14.48% | $60 → $51 | Maintains | Equal-Weight | Get Alert |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $6.80 | 76.47% | $31 → $12 | Maintains | Overweight | Get Alert |
| 08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $980.20 | -5.63% | $900 → $925 | Maintains | Overweight | Get Alert |
| 08/18/2023 | SKIL | Buy Now | Skillsoft | $8.29 | -69.84% | $58 → $50 | Maintains | Overweight | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $788.00 | -25.13% | $500 → $590 | Maintains | Overweight | Get Alert |
| 08/08/2023 | BIIB | Buy Now | Biogen | $235.32 | 24.94% | $311 → $294 | Maintains | Equal-Weight | Get Alert |
| 08/07/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $980.20 | -8.18% | $888 → $900 | Maintains | Overweight | Get Alert |
| 08/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $110 → $172 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $44.55 | 39.17% | $64 → $62 | Maintains | Equal-Weight | Get Alert |
| 07/24/2023 | GILD | Buy Now | Gilead Sciences | $67.12 | 19.19% | $81 → $80 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | PFE | Buy Now | Pfizer | $28.80 | 31.94% | $40 → $38 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | GILD | Buy Now | Gilead Sciences | $67.12 | 20.68% | $84 → $81 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | BMY | Buy Now | Bristol-Myers Squibb | $44.55 | 43.66% | $65 → $64 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | AMGN | Buy Now | Amgen | $319.04 | -34.18% | $225 → $210 | Maintains | Underweight | Get Alert |
| 06/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $980.20 | -9.41% | $915 → $888 | Maintains | Overweight | Get Alert |
| 06/28/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $98 → $110 | Maintains | Overweight | Get Alert |
| 06/08/2023 | BIIB | Buy Now | Biogen | $235.32 | — | — | Maintains | Overweight | Get Alert |
| 06/07/2023 | SKIL | Buy Now | Skillsoft | $8.29 | -65.02% | $70 → $58 | Maintains | Overweight | Get Alert |
| 05/11/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $90 → $98 | Maintains | Overweight | Get Alert |
| 05/09/2023 | ACLX | Buy Now | Arcellx | $51.72 | -5.26% | $38 → $49 | Maintains | Overweight | Get Alert |
| 05/05/2023 | ALEC | Buy Now | Alector | $5.65 | 112.39% | $14 → $12 | Maintains | Overweight | Get Alert |
| 05/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $142.00 | -11.97% | $131 → $125 | Maintains | Overweight | Get Alert |
| 05/03/2023 | PFE | Buy Now | Pfizer | $28.80 | 38.89% | $43 → $40 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | MRK | Buy Now | Merck & Co | $132.00 | -1.52% | $128 → $130 | Maintains | Overweight | Get Alert |
| 05/01/2023 | LLY | Buy Now | Eli Lilly | $788.00 | -46.7% | $400 → $420 | Maintains | Overweight | Get Alert |
| 05/01/2023 | BMY | Buy Now | Bristol-Myers Squibb | $44.55 | 45.9% | $66 → $65 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | AMGN | Buy Now | Amgen | $319.04 | -29.48% | $227 → $225 | Maintains | Underweight | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $235.32 | 28.34% | $307 → $302 | Maintains | Equal-Weight | Get Alert |
| 04/14/2023 | AMGN | Buy Now | Amgen | $319.04 | -28.85% | $230 → $227 | Maintains | Underweight | Get Alert |
| 04/12/2023 | PFE | Buy Now | Pfizer | $28.80 | 49.31% | $44 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | SKIL | Buy Now | Skillsoft | $8.29 | -57.78% | $80 → $70 | Maintains | Overweight | Get Alert |
| 03/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $980.20 | -6.65% | $815 → $915 | Maintains | Overweight | Get Alert |
| 03/21/2023 | GOSS | Buy Now | Gossamer Bio | $0.75 | 98.78% | $2 → $1.5 | Maintains | Equal-Weight | Get Alert |
| 03/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $50 → $90 | Maintains | Overweight | Get Alert |
| 02/21/2023 | TVTX | Buy Now | Travere Therapeutics | $6.80 | 355.88% | $37 → $31 | Maintains | Overweight | Get Alert |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $142.00 | -7.75% | $136 → $131 | Maintains | Overweight | Get Alert |
| 02/01/2023 | AMGN | Buy Now | Amgen | $319.04 | -27.91% | $240 → $230 | Maintains | Underweight | Get Alert |
| 02/01/2023 | PFE | Buy Now | Pfizer | $28.80 | 52.78% | $49 → $44 | Maintains | Equal-Weight | Get Alert |
| 01/18/2023 | GILD | Buy Now | Gilead Sciences | $67.12 | 25.15% | $76 → $84 | Maintains | Equal-Weight | Get Alert |
| 01/18/2023 | AMGN | Buy Now | Amgen | $319.04 | -24.77% | $234 → $240 | Maintains | Underweight | Get Alert |
| 01/03/2023 | LLY | Buy Now | Eli Lilly | $788.00 | -49.24% | $395 → $400 | Maintains | Overweight | Get Alert |
| 12/12/2022 | ACLX | Buy Now | Arcellx | $51.72 | -26.53% | $25 → $38 | Maintains | Overweight | Get Alert |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $0.75 | 165.04% | $18 → $2 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/30/2022 | BIIB | Buy Now | Biogen | $235.32 | 33.01% | $275 → $313 | Maintains | Equal-Weight | Get Alert |
| 11/11/2022 | VOR | Buy Now | Vor Biopharma | $1.75 | 757.14% | $26 → $15 | Maintains | Overweight | Get Alert |
| 11/11/2022 | MTEM | Buy Now | Molecular Templates | $1.47 | -31.97% | $67.5 → $15 | Maintains | Overweight | Get Alert |
| 11/09/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $43 → $50 | Maintains | Overweight | Get Alert |
| 11/02/2022 | PFE | Buy Now | Pfizer | $28.80 | 70.14% | $44 → $49 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | LLY | Buy Now | Eli Lilly | $788.00 | -49.87% | $355 → $395 | Maintains | Overweight | Get Alert |
| 10/31/2022 | ABBV | Buy Now | AbbVie | $163.89 | -5.42% | $160 → $155 | Maintains | Equal-Weight | Get Alert |
| 10/31/2022 | GILD | Buy Now | Gilead Sciences | $67.12 | 13.23% | $60 → $76 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/31/2022 | AMGN | Buy Now | Amgen | $319.04 | -26.66% | → $234 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/28/2022 | MRK | Buy Now | Merck & Co | $132.00 | -16.67% | $105 → $110 | Maintains | Overweight | Get Alert |
| 10/12/2022 | PFE | Buy Now | Pfizer | $28.80 | 52.78% | $50 → $44 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | GILD | Buy Now | Gilead Sciences | $67.12 | -10.61% | $56 → $60 | Maintains | Underweight | Get Alert |
| 10/12/2022 | BMY | Buy Now | Bristol-Myers Squibb | $44.55 | 48.15% | $69 → $66 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | AMGN | Buy Now | Amgen | $319.04 | -26.66% | $236 → $234 | Maintains | Equal-Weight | Get Alert |
| 10/07/2022 | BIIB | Buy Now | Biogen | $235.32 | 16.86% | $200 → $275 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $980.20 | -16.85% | $735 → $815 | Maintains | Overweight | Get Alert |
| 08/18/2022 | GOSS | Buy Now | Gossamer Bio | $0.75 | 2285.37% | $12 → $18 | Maintains | Overweight | Get Alert |
| 08/16/2022 | APLT | Buy Now | Applied Therapeutics | $4.39 | -48.78% | $2.5 → $2.25 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | NBIX | Buy Now | Neurocrine Biosciences | $142.00 | -20.42% | $110 → $113 | Maintains | Overweight | Get Alert |
| 08/01/2022 | PFE | Buy Now | Pfizer | $28.80 | 80.56% | $50 → $52 | Maintains | Equal-Weight | Get Alert |
| 08/01/2022 | ABBV | Buy Now | AbbVie | $163.89 | -2.37% | $174 → $160 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | MRK | Buy Now | Merck & Co | $132.00 | -23.48% | $97 → $101 | Maintains | Overweight | Get Alert |
| 07/21/2022 | BIIB | Buy Now | Biogen | $235.32 | -15.01% | $210 → $200 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | ALLK | Buy Now | Allakos | $1.18 | 111.86% | $7 → $2.5 | Maintains | Underweight | Get Alert |
| 05/11/2022 | ALEC | Buy Now | Alector | $5.65 | 147.79% | $42 → $14 | Maintains | Overweight | Get Alert |
| 05/04/2022 | BIIB | Buy Now | Biogen | $235.32 | -10.76% | $219 → $210 | Maintains | Equal-Weight | Get Alert |
| 05/02/2022 | BMY | Buy Now | Bristol-Myers Squibb | $44.55 | 52.64% | $66 → $68 | Maintains | Equal-Weight | Get Alert |
| 04/26/2022 | GOSS | Buy Now | Gossamer Bio | $0.75 | 1490.25% | $18 → $12 | Maintains | Overweight | Get Alert |
| 04/12/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $980.20 | -24% | $700 → $745 | Maintains | Overweight | Get Alert |
| 04/12/2022 | NBIX | Buy Now | Neurocrine Biosciences | $142.00 | -22.54% | $100 → $110 | Maintains | Overweight | Get Alert |
| 04/12/2022 | MRK | Buy Now | Merck & Co | $132.00 | -26.52% | $94 → $97 | Maintains | Overweight | Get Alert |
| 04/12/2022 | BIIB | Buy Now | Biogen | $235.32 | -6.94% | $235 → $219 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | AMGN | Buy Now | Amgen | $319.04 | -26.03% | $233 → $236 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | ABBV | Buy Now | AbbVie | $163.89 | 6.17% | $150 → $174 | Maintains | Equal-Weight | Get Alert |
| 03/30/2022 | MTEM | Buy Now | Molecular Templates | $1.47 | 206.12% | $120 → $67.5 | Maintains | Overweight | Get Alert |
| 03/21/2022 | VOR | Buy Now | Vor Biopharma | $1.75 | 1385.71% | $56 → $26 | Maintains | Overweight | Get Alert |
| 03/21/2022 | APLT | Buy Now | Applied Therapeutics | $4.39 | -43.09% | $7 → $2.5 | Maintains | Equal-Weight | Get Alert |
| 03/10/2022 | GILD | Buy Now | Gilead Sciences | $67.12 | -16.57% | $63 → $56 | Maintains | Underweight | Get Alert |
| 02/09/2022 | AMGN | Buy Now | Amgen | $319.04 | -26.97% | $228 → $233 | Maintains | Equal-Weight | Get Alert |
| 02/03/2022 | ABBV | Buy Now | AbbVie | $163.89 | -8.48% | $133 → $150 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | PAYC | Buy Now | Paycom Software | $177.75 | 113.78% | $392 → $380 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | NBIX | Buy Now | Neurocrine Biosciences | $142.00 | -29.58% | $110 → $100 | Maintains | Overweight | Get Alert |
| 01/20/2022 | BIIB | Buy Now | Biogen | $235.32 | 3.69% | $280 → $244 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | ABBV | Buy Now | AbbVie | $163.89 | -18.85% | $118 → $133 | Maintains | Equal-Weight | Get Alert |
| 01/04/2022 | APLT | Buy Now | Applied Therapeutics | $4.39 | 59.34% | $44 → $7 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/22/2021 | ALLK | Buy Now | Allakos | $1.18 | 577.97% | $36 → $8 | Maintains | Underweight | Get Alert |
| 12/20/2021 | LLY | Buy Now | Eli Lilly | $788.00 | -58.76% | — | Maintains | Overweight | Get Alert |
| 12/16/2021 | TVTX | Buy Now | Travere Therapeutics | $6.80 | 488.24% | — | Maintains | Overweight | Get Alert |
| 12/10/2021 | PFE | Buy Now | Pfizer | $28.80 | 87.5% | — | Maintains | Equal-Weight | Get Alert |
| 12/09/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | — | Maintains | Overweight | Get Alert |
